CryoLife (NYSE: CRY) reported Q4 EPS of $0.06, $0.01 better than the analyst estimate of $0.05. Revenue for the quarter came in at $39.8 million versus the consensus estimate of $40.04 million.

GUIDANCE:

CryoLife sees FY2016 EPS of $0.29-$0.32, versus the consensus of $0.22. CryoLife sees FY2016 revenue of $170-180 million, versus the consensus of $154.4 million.

For earnings history and earnings-related data on CryoLife (CRY) click here.